You can do a cell-free fetal DNA screening, a non-invasive prenatal screening test (NIPT) in our Berehynia Medical Center. It is the most accurate non-invasive method for diagnosing chromosomal abnormalities in the fetus.

This test is the analysis of fetal DNA that circulates freely in the maternal blood (cell-free fetal DNA) to detect  the most common fetal aneuploidies, such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13) and anomalies of X and Y sex chromosomes (Turner syndrome, Klinefelter syndrome).

Cell-free DNA screening/NIPT test includes five levels depending on the depth of study:

1. FetalDNA base: a patented CE/IVD certified test. This high-precision test detects trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) and, upon request, determines the sex of an unborn child.
2. FetalDNA base Plus: a patented CE/IVD certified test. This high-precision test detects trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome, upon request, determines the sex of an unborn child and identifies anomalies of sex chromosomes X, Y (Turner syndrome, Klinefelter syndrome), monosomy X. 
3. FetalDNA cariotipo: a patented CE/IVD certified test. This high-precision test detects trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome), determines the sex of an unborn child, detects abnormalities of sex chromosomes X, Y, monosomy X and conducts a detailed analysis of the number and structure of all 23 pairs of chromosomes that make up the karyotype.
4. FetalDNA cariotipo Plus: patented CE/IVD certified test. This high-precision test detects trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome), detects abnormalities of sex chromosomes X, Y, monosomy X, conducts a detailed analysis of the number and structure of all 23 pairs of chromosomes that make up the karyotype, and, upon request, determines the sex of an unborn child. In addition to the analysis of all chromosomal fetal aneuploidies, the test detects numerous microscopic structural changes of chromosomes, namely, microdeletion syndromes (Cri du chat, DiGeorge, Angelman, Wolf-Hirschhorn, Jacobsen, Langer-Giedion, Smith-Magenis, Prader-Willi, Williams, Koolen-de Vries, Alagille, Rubinstein-Taybi, WAGR, Potocki-Shaffer, Miller-Dieker, Kleefstra, Phelan-McDermid, p36, 18q, 1q21.1 deletion syndromes and HNPP disorders).

      The maternal blood is tested free of charge for cystic fibrosis gene mutations.

1. Fetal DNA Total Screen (New): patented CE/IVD certified test.

The test includes:

•   FetalDNA Cariotipo Plus
•   Monogenic fetal diseases:

cystic fibrosis, congenital hearing loss, beta thalassemia, congenital adrenal hyperplasia, hemochromatosis, achondroplasia, hypochondroplasia, skeletal dysplasia, Apert syndrome, Crouzon syndrome, Pfeiffer syndrome, LEOPARD syndrome, Noonan syndrome, phenylketonuria, Rett syndrome, autosomal recessive polycystic kidney disease

•   Cystic fibrosis (maternal)
•   Genetic screening for mutations that cause preterm birth
•   Biochemical predictive markers
•   Pre-eclampsia
•   Spinal muscular atrophy (CMA) (maternal)
• Hereditary thrombophilia (maternal)
•  Infectious diseases